Stay updated on SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Sign up to get notified when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.

Latest updates to the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check77 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed descriptions of a Phase 1 study for SCR-6920 and the addition of a new revision number. The study's focus on solid tumors remains, but specific details about the study's design and inclusion/exclusion criteria have been deleted.SummaryDifference20%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.